Articles written by Hannah Shoctor
Clearing the Confusion: New Multisociety Practice Guidance and a Critical Review of GLP-1RA Literature
As of January 2025, GLP-1RAs, including semaglutide and liraglutide, have been approved for weight loss management, with ongoing studies exploring their benefits when used to treat other metabolic conditions and populations. Given the growing popularity of GLP-1RAs, it is crucial for anesthesiologists to understand their perioperative implications.
Read the article


